4AB:FRA
AbbVie Common Stock
€254.80
arrow_downward
-0.74%(-1.90) 1D
Oct 16, 10:00:00 PM GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 4AB...
Open
€251.00
High
€254.80
Low
€251.00
Mkt. cap
504.37B
Avg. vol.
71.00
Volume
14.00
52-wk high
€254.80
52-wk low
€167.55
No. of employees
57K
Open
€251.00
High
€254.80
Low
€251.00
Mkt. cap
504.37B
Avg. vol.
71.00
Volume
14.00
52-wk high
€254.80
52-wk low
€167.55
No. of employees
57K
News stories
From web sources and news partners
24/7 Wall St.
·
7 hours ago
AbbVie’s Dividend Keeps Climbing. Is It Still a Buy for Income Investors?
Yahoo Finance
·
10 hours ago
Forget High-Yield Traps: AbbVie Is the Dividend King to Buy and Hold Through Any Rate Cycle
ad-hoc-news.de
·
10 hours ago
AbbVie stock heads into the next Xetra session at EUR 253.10
Profile
AbbVie Inc., also known as AbbVie, is an American pharmaceutical company headquartered in North Chicago, Illinois. AbbVie produces drugs to treat a wide range of medical issues.
The company is ranked sixth on the list of largest biomedical companies by revenue. It is ranked 77th on the Fortune 500 and 108th on the Forbes Global 2000. The name "AbbVie" is derived from a combination of "Abbott", the name of its former parent company, with "vie", intended as a reference to a Latin root meaning 'life'. Wikipedia
About AbbVie Common Stock
CEORobert A. Michael
Employees57K
FoundedApr 10, 2012
HeadquartersNorth Chicago, Illinois, United States
SectorBiotechnology
Websiteabbvie.com